Correlation of Body Mass Index with Anthropometric and Biochemical Parameters Among Polycystic Ovary Syndrome Phenotypes

被引:3
作者
Mehra, Tanuja [1 ]
Sharma, Sonali [1 ]
Zahra, Tasneem [2 ]
Jangir, Sapna [1 ]
Gupta, Barkha [1 ]
机构
[1] RUHS Coll Med Sci, Dept Biochem, Sect 11,Kumbha Marg, Jaipur 302033, Rajasthan, India
[2] RUHS Coll Med Sci, Dept Obstet & Gynaecol, Sect 11,Kumbha Marg, Jaipur, Rajasthan, India
关键词
Body mass index; Sub-clinical hypothyroidism; Polycystic ovary syndrome; Phenotypes; SUBCLINICAL HYPOTHYROIDISM; METABOLIC PROFILE; HYPERANDROGENISM; HIRSUTISM; WOMEN;
D O I
10.1007/s12291-022-01042-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This was a prospective observational study, conducted at a tertiary care health centre in Rajasthan. A total of 68 women with PCOS (Rotterdam criteria) attending OPD at Department of Obstetrics and Gynecology qualified as per inclusion and exclusion criteria were included in the study. Each participant was examined for anthropometric and biochemical parameters. The largest phenotypic group was phenotype A, (41.17%); followed by B (26.47%); C (20.58%), and D (P + O) phenotypes (11.76%). Hyperandrogenic phenotypes (A, B, C), had significantly higher prevalence of deranged serum glucose (fasting and postprandial), lipid profile and serum TSH than normoandrogenic phenotype D. BMI was strongly correlated with anthropometric (p < 0.001) and biochemical parameters (p < 0.05) in phenotype A among four phenotypes of PCOS. Phenotype A was the most common form of PCOS and a strong correlation of BMI with waist circumference (WC), dyslipidemia and Sub-clinical hypothyroidism (SCH) was observed in women of this phenotype of PCOS. These results indicate that phenotype A is at increased risk of CVD and diabetes and phenotype D has least metabolic risks.
引用
收藏
页码:231 / 241
页数:11
相关论文
共 50 条
  • [21] Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
    Senturk, Senol
    Hatirnaz, Safak
    Kanat-Pektas, Mine
    MEDICAL SCIENCE MONITOR, 2018, 24 : 7517 - 7523
  • [22] Body mass index and basal androstenedione are independent risk factors for miscarriage in polycystic ovary syndrome
    Wan Yang
    Rui Yang
    Mingmei Lin
    Yan Yang
    Xueling Song
    Jiajia Zhang
    Shuo Yang
    Ying Song
    Jia Li
    Tianshu Pang
    Feng Deng
    Hua Zhang
    Ying Wang
    Rong Li
    Jie Jiao
    Reproductive Biology and Endocrinology, 16
  • [23] Correlation between biochemical and clinical hyperandrogenism parameter in polycystic ovary syndrome in relation to age
    Guo, Zaixin
    Jin, Fengjun
    Chen, Shuwen
    Hu, Pan
    Hao, Yanfang
    Yu, Qi
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [24] Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes - a cross-sectional study
    Gupta, Monica
    Yadav, Ritu
    Mahey, Reeta
    Agrawal, Anisha
    Upadhyay, Ashish
    Malhotra, Neena
    Bhatla, Neerja
    GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (11) : 970 - 973
  • [25] Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria
    Yilmaz, Mehmet
    Isaoglu, Unal
    Delibas, Ilhan Bahri
    Kadanali, Sedat
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2011, 37 (08) : 1020 - 1026
  • [26] Correlation of serum homocysteine levels and hyperinsulinaemia with body mass index in polycystic ovarian syndrome
    Bhushan, Rashmi
    Sinha, Parul
    JOURNAL OF HUMAN REPRODUCTIVE SCIENCES, 2022, 15 (01) : 34 - 41
  • [27] Polycystic ovary syndrome, body mass index and hypertensive disorders in pregnancy
    Lonnebotn, Marianne
    Natvig, Gerd Karin
    Benediktsdottir, Bryndis
    Burgess, John A.
    Holm, Mathias
    Jogi, Rain
    Lindberg, Eva
    Macsali, Ferenc
    Schlunssen, Vivi
    Skulstad, Svein Magne
    Franklin, Karl A.
    Vanky, Eszter
    Real, Francisco Gomez
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2018, 11 : 32 - 37
  • [28] The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone
    Lee, Malinda S.
    Lanes, Andrea
    Dolinko, Andrey, V
    Bailin, Alexandra
    Ginsburg, Elizabeth
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2020, 37 (09) : 2293 - 2304
  • [29] The effects of behavioral intervention on anthropometric, clinical, and biochemical parameters in patients with polycystic ovary syndrome: a systematic review and meta-analysis
    Xie, Min
    Yang, Yang
    Zhang, Jing
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [30] Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study
    Zhao, Yalin
    Xu, Yuping
    Wang, Xiaomeng
    Xu, Lin
    Chen, Jianhua
    Gao, Chengwen
    Wu, Chuanhong
    Pan, Dun
    Zhang, Qian
    Zhou, Juan
    Chen, Ruirui
    Wang, Zhuo
    Zhao, Han
    You, Li
    Cao, Yunxia
    Li, Zhiqiang
    Shi, Yongyong
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (06) : 1778 - 1784